PASITHEA THERAPEUTICS CORP. Other Current Assets
PASITHEA THERAPEUTICS CORP. (KTTA) had Other Current Assets of $22.54 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-08-14
- 2026-06-30: Other Assets, Current $22.54K.
- 2026-03-31: Other Assets, Current $400.47K.
- 2025-12-31: Other Assets, Current $387.82K.
- 2025-09-30: Other Assets, Current $19.66K.
| Period end | Other Assets, Current | Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $22.54K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $400.47K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $387.82K 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $19.66K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $117.84K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $162.45K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $142.94K 10-K · filed 2026-03-30 | |
| 2024-09-30 | $98.33K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $104.65K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $104.65K 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $104.71K 10-K · filed 2025-03-24 | |
| 2023-09-30 | $106.51K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $452.19K 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $262.99K 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $262.99K 10-K · filed 2024-03-29 | $302.13K 10-K · filed 2023-03-30 |
| 2022-09-30 | $865.99K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $79.59K 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |